Top Markets
#1 Status Status +21.05%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.55%
#3 Fake World Assets Fake World Assets +14.92%
#4 Ontology Gas Ontology Gas +12.78%
#5 GoPlus Security GoPlus Security +12.22%
#6 DMT-NAT DMT-NAT +8.79%
#7 Nillion Nillion +6.92%
#8 Provenance Blockchain Provenance Blockchain +6.68%
#9 Janction Janction +6.46%
#10 Bedrock Bedrock +5.82%
Coin of the day
Status Status
設定
言語
日本
通貨
USD
テーマ
Kineta, Inc. Kineta, Inc.

Kineta, Inc.

KA
株式のランク #34154
Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing... Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing immunotherapies, with a focus on oncology, neuroscience, and biodefense applications. The company engages in partnerships with a variety of entities, including private companies, government bodies, and other industry stakeholders. Among its significant strategic collaborators are Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Established in 2007, Kineta, Inc. was previously known as Lecura, Inc. and has its base of operations in Seattle, Washington.
株価
$0.617
最終同期: 2024-10-14
時価総額
$6.13M
変化（1日）
0.49%
変化（1年）
0.00%
国
US
取引 Kineta, Inc. (KA)

カテゴリー

Healthcare
Kineta, Inc.（KA）のP/S比率
August 2026 時点のP/S比率 TTM: 0.00
Kineta, Inc. の最新の財務報告および株価によると、現在のP/S比率（TTM）は 0.00 です。2023 年末時点でのP/S比率は 7.37 でした。
Kineta, Inc. の P/S 比率の履歴（2015 ～ 2026）
各年末時点のP/S比率
年 P/S比率 変化
2026 (TTM) 0.00 -100.00%
2024 0.00 -100.00%
2023 7.37 -53.96%
2022 16.02 516.56%
2021 2.60 -12.26%
2020 2.96 -83.64%
2019 18.09 -46.90%
2018 34.07 58.35%
2017 21.52 1.10%
2016 21.28 -28.43%
2015 29.74 0.00%
同業他社のP/S比率
企業 P/S比率 P/S比率の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -
BE